(Q54609789)

1 June 2018

title

Neoadjuvant anthracycline and trastuzumab for breast cancer: is concurrent treatment safe? (English)

1 reference

1 June 2018

1 reference

6

1 reference

1 June 2018

author name string

Ivana Bozovic-Spasojevic

1

1 reference

1 June 2018

Hatem A Azim

2

1 reference

1 June 2018

Marianne Paesmans

3

1 reference

1 June 2018

Thomas Suter

4

1 reference

1 June 2018

Martine J Piccart

5

1 reference

1 June 2018

publication date

25 February 2011

1 reference

1 June 2018

Lancet Oncology Commission

published in

1 reference

1 June 2018

volume

12

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

209-211

1 reference

1 June 2018

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parall

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Pathophysiology and diagnosis of cancer drug induced cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970013-4

7 January 2021

10.1016/S1470-2045(11)70013-4

Identifiers

DOI

1 reference

1 June 2018

release_yuviw3ctfve5rbioptyub3arcy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yuviw3ctfve5rbioptyub3arcy

24 November 2022

mapped directly with Wikidata item

1 reference

1 June 2018